Senior Vice President, Worldwide Head of Medical Affairs, Neuroscience

About the Role

Bristol Myers Squibb (BMS) is seeking an accomplished, enterprise-minded scientific and business leader to serve as Senior Vice President, Worldwide Head of Medical Affairs, Neuroscience. This executive will lead the integrated worldwide medical strategy and execution across BMS's neuroscience portfolio, spanning psychiatric, neurodegenerative, and neuroinflammatory disorders. This is the senior-most Medical Affairs leadership role for Neuroscience and a critical enterprise position.

The SVP will influence where BMS should lead in this space, contribute to portfolio and investment choices, and drive scientific and operational excellence from early development through commercialization, shaping the future of neuroscience care and ensuring BMS delivers meaningful impact to patients worldwide. Accountable for maximizing the patient impact of the growth portfolio and expanding the clinical value of the pipeline for patients, the SVP will shape decisions from early development through launch and lifecycle management.

The SVP will sit on the Worldwide Medical Leadership Team, report directly to the Head of the Medical Affairs worldwide, and serve as the global medical representative for BMS Neuroscience.

Responsibilities

• Enterprise Strategy & Portfolio Leadership
  • Own the long-range worldwide Medical Affairs vision and integrated strategy for Neuroscience, setting priorities, resource allocation, and measurable outcomes across Global, U.S., and International markets.
  • Co-shape the enterprise Neuroscience strategy by integrating patient need, emerging science, competitive dynamics, access realities, and external innovation.
  • Provide decisive medical leadership in enterprise governance, including portfolio prioritization, asset and indication sequencing, investment trade-offs, and decisions on what to stop, scale, or accelerate.
  • Align Discovery, Development, Regulatory, Commercial, Market Access, Business Development, and markets around a coherent portfolio narrative and execution roadmap.
• Pipeline, Asset Strategy & Value Expansion
  • Partner with Discovery and R&D from early development to shape target product profiles, development plans, trial design, endpoints, biomarker and precision-medicine strategies, and evidence requirements that reflect evolving science and patient need.
  • Identify unmet needs and evidence gaps – delivering early signal-seeking, proof-of-concept, translational science, and real-world evidence strategies that strengthen differentiation and accelerate decision-making.
  • Expand the clinical value of the portfolio for patients through lifecycle strategy, including new indications, combinations, patient populations, practice-informing studies, and label-enabling evidence.
  • Anticipate changes in science, standards of care, and the competitive landscape, and convert those insights into timely portfolio and asset decisions.
• Business Development & External Innovation
  • Partner with Business Development, R&D, and enterprise strategy leaders to define scientific white spaces and identify external opportunities, including licensing, acquisitions, research alliances, co-development, and academic collaborations.
  • Lead Medical Affairs input into scientific and medical due diligence, assessing strategic fit, differentiation, unmet need, development feasibility, evidence requirements, access and adoption considerations, and potential patient impact.
  • Represent Medical Affairs in deal governance and investment decisions, providing clear recommendations on clinical relevance, portfolio fit, and value-creation potential.
  • Ensure disciplined transition from transaction to execution by establishing medical governance, integrating acquired or partnered assets into portfolio and evidence plans, and serving as an executive sponsor for priority alliances.
• Integrated Evidence, Access & Patient Impact
  • Lead integrated evidence plans across the worldwide Neuroscience portfolio, aligned with asset strategy, regulatory and health-system needs, market access goals, and the evolving standard of care.
  • Embed the patient journey, diverse patient perspectives, health equity, and real-world practice into early development, launch, and lifecycle strategy through continuous insight generation and evidence application.
  • Partner with Clinical Development, HEOR, Market Access, Commercial, Policy, and markets to generate evidence that supports scientific differentiation, patient impact, and timely, equitable access.
  • Define and track outcomes that demonstrate impact - including changes in scientific understanding, clinical practice, care-gap closure, access, and patient outcomes - rather than activity volume alone.
• Organization, Operating Model & Execution
  • Build and lead a high-performing, inclusive, and globally integrated team across headquarters, regional, market, and field medical functions, with clear accountability for strategy and outcomes.
  • Allocate resources dynamically across assets, markets, and priorities to maximize enterprise value and patient impact.
  • Establish clear decision rights, governance, and operating rhythms that enable speed, cross-functional alignment, scientific integrity, and compliant execution.
  • Use advanced analytics, digital capabilities, and performance measures to improve decision quality, stakeholder engagement, execution agility, and continuous improvement.
• External Leadership, Alliances & Reputation
  • Serve as the global medical voice and visible external leader for BMS Neuroscience with regulatory authorities, academic and community institutions, professional societies, patient organizations, health systems, and population decision-makers.
  • Build strategic partnerships across academia, biotechnology, advocacy, public-private organizations, and medical societies that accelerate innovation, evidence generation, access, and BMS's position as a partner of choice.
  • Elevate BMS's scientific leadership and reputation through credible, high-impact engagement with the global neuroscience community.

Qualifications

• Advanced doctorate degree in medicine, neuroscience, psychiatry, or a related field; MD or DO required.
• 10+ years of progressive leadership experience in the biopharmaceutical industry, with a strong record in Neuroscience and global Medical Affairs and/or Clinical Development.
• Deep scientific and strategic expertise in psychiatric, neurodegenerative, or neuroinflammatory disorders, with the breadth to lead an integrated Neuroscience portfolio.
• Demonstrated success building enterprise therapeutic-area and portfolio strategy, influencing prioritization and investment decisions, and translating strategy into measurable outcomes.
• Experience in business development, scientific due diligence, external innovation, licensing or acquisitions, and alliance governance strongly preferred.
• Leadership across early and late-stage development, regulatory interactions, integrated evidence generation, launch and lifecycle management.
• Experience in both major-market and global settings is required; direct R&D experience is strongly preferred.
• Proven ability to lead large, diverse, geographically distributed teams and to operate effectively across complex, matrixed environments.
• Exceptional executive presence, judgment, and communication, with the ability to influence senior leaders, governance bodies, external partners, and the global scientific community.
• Recognized scientific and clinical credibility, supported by a strong record of external engagement, collaboration, and contribution to the field.

Leadership Expectations

• Accountability - Act with clarity and ownership, make decisions, and deliver results.
• Strategic leadership - Set direction, make disciplined choices, and mobilize the enterprise around the highest-impact opportunities.
• Execution excellence - Convert strategy into outcomes with precision, speed, and sustained follow-through.
• Diverse thinking - Use global perspectives and constructive challenge to unlock better decisions and innovation.
• Patient focus - Relentlessly prioritize meaningful improvements in the lives of patients and caregivers.

About Bristol Myers Squibb

Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams rich in diversity.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.

Schedule

BMS has a diverse occupancy structure that determines where an employee is required to conduct their work. This structure includes site-essential, site-by-design, field-based, and remote-by-design jobs. The occupancy type that you are assigned is determined by the nature and responsibilities of your role:

• Site-essential roles require 100% of shifts onsite at your assigned facility.
• Site-by-design roles may be eligible for a hybrid work model with at least 50% onsite at your assigned facility. For these roles, onsite presence is considered an essential job function and is critical to collaboration, innovation, productivity, and a positive Company culture.
• For field-based and remote-by-design roles, the ability to physically travel to visit customers, patients, or business partners and to attend meetings on behalf of BMS as directed is an essential job function.